BioNTech SE

BRSE:22UA Stock Report

Market Cap: CHF 18.2b

BioNTech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 22UA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,9270.000762%
Individual Insiders41,081,42116.2%
Institutions50,951,22420.1%
General Public59,147,31123.4%
VC/PE Firms101,702,37840.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 71.04% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
40.2%
AT Impf GmbH
101,702,378CHF 7.3b0.42%100.0%
15.9%
Ugur Sahin
40,076,320CHF 2.9b-2.84%no data
2.32%
T. Rowe Price Group, Inc.
5,856,073CHF 422.4m30.6%0.04%
2.25%
FMR LLC
5,678,512CHF 409.6m-3.49%0.02%
1.5%
PRIMECAP Management Company
3,793,711CHF 273.7m-0.17%0.2%
1.46%
Flossbach von Storch SE
3,680,315CHF 265.5m-12.3%0.86%
1.45%
Dodge & Cox
3,676,791CHF 265.2m1.72%0.09%
0.66%
BlackRock, Inc.
1,658,153CHF 119.6m43.8%no data
0.65%
BNP Paribas Financial Markets SNC
1,651,789CHF 119.2m4.67%0.08%
0.6%
Temasek Holdings (Private) Limited
1,506,027CHF 108.6m0%0.08%
0.41%
UBS Asset Management AG
1,024,533CHF 73.9m108%0.01%
0.38%
Citadel Advisors LLC
951,372CHF 68.6m40.3%0.06%
0.35%
Bank of America Corporation
892,292CHF 64.4m23.4%0.02%
0.35%
GSK Equity Investments, Limited
889,824CHF 64.2m0%8.23%
0.35%
Baillie Gifford & Co.
882,572CHF 63.7m-29.1%0.04%
0.33%
First Trust Advisors LP
839,991CHF 60.6m116%0.04%
0.27%
Massachusetts Financial Services Company
670,514CHF 48.4m0%0.01%
0.26%
Salvia GmbH
656,951CHF 47.4m2.07%no data
0.25%
Long Focus Capital Management LLC
624,000CHF 45.0m22.9%2.25%
0.21%
Sierk Pötting
542,539CHF 39.1m-8.44%no data
0.19%
Candriam, Société En Commandite Par Actions
488,367CHF 35.2m-19.3%0.11%
0.19%
Deka Investment GmbH
481,397CHF 34.7m0%0.03%
0.19%
Victory Capital Management Inc.
476,923CHF 34.4m19.1%0.02%
0.19%
Morgan Stanley
473,424CHF 34.2m-29.5%no data
0.19%
Tang Capital Management, LLC
470,000CHF 33.9m0%1.94%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/14 12:11
End of Day Share Price 2026/06/08 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioNTech SE is covered by 31 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Harry GillisBerenberg
Zhiqiang ShuBerenberg
Samuel EnglandBerenberg